Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community

BACKGROUND: The Pfizer BioNTech COVID-19 vaccine was the first to receive emergency authorization and approval from the FDA. Therefore, it is preferred by most recipients; however, many people are concerned about the vaccine’s side effects. At the time of the study, December 2021, Palestine lacked a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abukhalil, Abdallah Damin, Shatat, Sireen Sultan, Abushehadeh, Raya Riyad, Al-Shami, Ni’meh, Naseef, Hani A., Rabba, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814351/
https://www.ncbi.nlm.nih.gov/pubmed/36604613
http://dx.doi.org/10.1186/s12879-022-07974-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814351/
https://www.ncbi.nlm.nih.gov/pubmed/36604613
http://dx.doi.org/10.1186/s12879-022-07974-3

Ejemplares similares